Kukat, A. | Search bioRxiv

bioRxiv2023

SPTF-3/SP1 orchestrates mitochondrial biogenesis upon ribosomal stress and acute starvation

When cells have increased energy demand, they respond by elevating the production of new mitochondria through the process of mitochondrial biogenesis. This complex physiological undertaking requires precise coordination of mitochondrial and nuclear gene expression to extend the existing mitochondrial network in the cell. Using C. elegans as a model system we have identified stress-induced transcription factor SPTF-3 as a novel regulator of mitochondrial biogenesis on-demand upon increased heat stress, dietary restriction, and acute starvation. We show that SPTF-3 also regulates ATFS-1, the main transcriptional regulator of UPRmt (mitochondrial unfolded protein response). Thus, by orchestrating two parallel programs - mitochondrial biogenesis and UPRmt, SPTF-3 safeguards mitochondrial wellbeing and function upon stress, thus allowing survival in unfavorable conditions. Mitochondrial biogenesis is induced by disturbances in cytoplasmic ribosomal assembly, which leads to preferential translation of SPTF-3. Importantly, we demonstrated that the role of SPTF-3 in the regulation of mitochondrial biogenesis upon nutrient deprivation is conserved in mammals through its homolog SP1.

molecular biology↗

bioRxiv2020

Adaptive mitochondrial regulation of the proteasome

The proteasome is the main proteolytic system for targeted protein degradation in the cell. Its function is fine-tuned according to cellular needs. Regulation of proteasome function by mitochondrial metabolism, however, is unknown. Here, we demonstrate that mitochondrial dysfunction reduces the assembly and activity of the 26S proteasome in the absence of oxidative stress. Impaired respiratory complex I function leads to metabolic reprogramming of the Krebs cycle and deficiency in aspartate. Aspartate supplementation activates assembly and activity of 26S proteasomes via transcriptional activation of the proteasome assembly factors p28 and Rpn6. This metabolic adaptation of 26S proteasome function involves sensing of aspartate via the mTORC1 pathway. Metformin treatment of primary human cells similarly reduced assembly and activity of 26S proteasome complexes, which was fully reversible and rescued by supplementation of aspartate or pyruvate. Of note, respiratory dysfunction conferred resistance towards the proteasome inhibitor Bortezomib. Our study uncovers a fundamental novel mechanism of how mitochondrial metabolism adaptively adjusts protein degradation by the proteasome. It thus unravels unexpected consequences of defective mitochondrial metabolism in disease or drug-targeted mitochondrial reprogramming for proteasomal protein degradation in the cell. As metabolic inhibition of proteasome function can be alleviated by treatment with aspartate or pyruvate, our results also have therapeutic implications.

cell biology↗